The Global AI in Clinical Trials Market size was accounted for US$ 1.56 Billion in 2023 and. Is expected to reach US$ 5.32 Billion in 2031, & is anticipated to reflect a CAGR of 17.2% during the period of 2024-2031. The AI in clinical trials market is experiencing rapid expansion, driven by the increasing adoption of artificial intelligence to streamline drug discovery, optimize patient...

In 2023, the global clinical trials market was valued at USD 80.7 billion and is anticipated to grow at a compound annual growth rate (CAGR) of 6.49% from 2024 to 2030. Market growth was notably influenced by the COVID-19 pandemic, which in 2020 led to increased demand for both virtual and traditional clinical trials. Many companies made significant investments in developing new drugs to...